Last updated: 2026-10-01 01:12:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
SeaStar Medical Holding Corporation (ICU) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3.91, with a market capitalization of $14.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.07 to $7.35. This page covers its latest market performance, valuation, price trends and company information.
$14.98M | |
$3.62 | |
$3,050.00 | |
$2.07 | |
$3.56 | |
84.00K | |
72.48K | |
-- | |
$7.35 | |
$2.07 | |
-- | |
-- |
SeaStar Medical Holding Corporation (ICU) last closed at $3.56 as of 2026-10-01 00:00:00, unchanged from the previous close of $3.56.
During the latest regular trading session, ICU traded between $2.07 and $3,050.00, with a volume of 84.00K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, SeaStar Medical Holding Corporation (ICU) moved from $3.58 to $3.91, representing a gain of 9.16% ($0.33).
The stock traded between $3.22 and $4.08 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 35.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 34.8%
ICU is currently trading at $3.91, placing it 34.8% of the way from its 52-week low of $2.07 to its 52-week high of $7.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SeaStar Medical Holding Corporation (ICU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.